TELA Bio CEO Heather C. Getz Buys 12,500 Shares

What Happened

• Heather C. Getz, CEO of TELA Bio, purchased 12,500 shares in an open-market transaction on August 17, 2026. The Form 4 reports a weighted average price of $0.66 per share for a total acquisition value of $8,311. The transaction is coded "P" (purchase), a straightforward buy rather than a sale.

Key Details

• Transaction date: 2026-08-17; Filing date: 2026-08-19 (filed two days after the trade, which is within the usual two-business-day Form 4 window).
• Price: weighted average $0.66 per share; reported price range across multiple purchases was $0.6504 to $0.6749 (footnote F1).
• Shares acquired: 12,500; Total reported value: $8,311.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote F1: the $0.66 is a weighted average; the filer can provide a breakdown of the number of shares bought at each price within the stated range on request.
• No 10b5‑1 plan, tax withholding, option exercise, or gift notation appears in the provided data.

Context

• Purchases by executives can be interpreted by investors as a personal investment in the company, but the size here is modest (~$8.3K) and should be weighed with broader insider activity and company fundamentals.
• This was an open-market buy (not an option exercise or grant), and there are no indications from the filing that the transaction was part of a planned trading program.